Factors Affecting Contraception Access and Use in Patients With Opioid Use Disorder. (3rd December 2020)

• Record Type: Journal Article
• Authors: Stone, Rebecca H.; Griffin, Brooke; Fusco, Rachel A.; Vest, Kathy; Tran, Tran; Gross, Savannah
• Other Names: Kim Myong‐Jin guestEditor.; Jarugula Venkateswar guestEditor.
• Is Part Of: Journal of clinical pharmacology. Volume 60(2020)Supplement 2
• Page Start: S63
• Page End: S73
• Publication Date: 2020-12-03
• Subjects: birth control -- condom -- contraception -- family planning -- neonatal abstinence syndrome -- opioid use disorder -- pregnancy -- substance use disorder; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Pharmacology, Clinical -- Periodicals; 615.1
• DOI: 10.1002/jcph.1772
• Languages: English
• ISSNs: 0091-2700

Abstract

Abstract: Maternal opioid use disorder increased > 4‐fold from 1999 to 2014 and is associated with poor maternal and fetal outcomes. Women with opioid use disorder are at 2 to 3 times greater risk for unintended pregnancy than the general population and may face additional barriers to accessing and effectively using contraception compared to women without opioid use disorder, particularly highly effective long‐acting reversible contraception. Additionally, women with opioid use disorder tend to use less effective forms of contraception such as condoms alone. Barriers to contraceptive access include patient misconceptions or knowledge gaps regarding reproductive health and family planning, cost, intimate partner violence, fear of criminalization, difficulty accessing care, comorbid health conditions, and health care provider misconceptions or practice limitations. Strategies that may assist women with opioid use disorder in achieving their family planning goals include colocation of family planning services within opioid treatment facilities, optimization of patient care services to minimize the need for costly and/or time consuming follow‐up, increasing provider education and awareness of best practices in family planning and opioid use disorder treatment, and providing patient‐centered family planning education and counseling. Additional research is needed to identify and develop strategies that empower women who use opioids to effectively access and use their preferred contraceptive method.